+

PE20030320A1 - Derivados sustituidos de 4-aminociclohexanol - Google Patents

Derivados sustituidos de 4-aminociclohexanol

Info

Publication number
PE20030320A1
PE20030320A1 PE2002000624A PE2002000624A PE20030320A1 PE 20030320 A1 PE20030320 A1 PE 20030320A1 PE 2002000624 A PE2002000624 A PE 2002000624A PE 2002000624 A PE2002000624 A PE 2002000624A PE 20030320 A1 PE20030320 A1 PE 20030320A1
Authority
PE
Peru
Prior art keywords
cycloalkyl
alkyl
aminociclohexanol
cyclohexanol
dimethylamine
Prior art date
Application number
PE2002000624A
Other languages
English (en)
Inventor
Hagen-Heinrich Hennies
Stephan Wnendt
Bernd Sundermann
Babette-Yvonne Kogel
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10135637A external-priority patent/DE10135637A1/de
Priority claimed from DE10135635A external-priority patent/DE10135635A1/de
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of PE20030320A1 publication Critical patent/PE20030320A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A DERIVADOS SUSTIUIDOS DE 4-AMINOCICLOHEXANOL DE FORMULA I DONDE R1 Y R2 SON H, ALQUILO C1-C8, CICLOALQUILO C3-C8, HETEROARILO, ARILO UNIDO MEDIANTE ALQUILENO C1-C3 DONDE NI R1 NI R2 PUEDEN SER H; LOS RESTOS R1 Y R2 EN FORMA CONJUNTA FORMAN UN CICLO Y SIGNIFICAN CH2CH2OCH2CH2, CH2CH2NR5CH2CH2, (CH2)3-6 CON R5 SELECCIONADA DE H, ALQUILO C1-C8, CICLOALQUILO C3-C8, ENTRE OTROS; R3 ES ALQUILO C1-C8, CICLOALQUILO C3-C8, ENTRE OTROS; R4 ES CICLOALQUILO C3-C8, ARILO, HETEROARILO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS 4-BENCIL-4-DIMETILAMINO-1-FENETIL-CICLO-HEXANOL, 4-DIMETILAMINO-1,4-DIFENETIL-CICLOHEXANOL, 4-BENCIL-4-DIMETILAMINO-1-[2-(2-FLUOR-FENIL)-ETIL]CICLOHEXANOL, COMO TAMBIEN EL HIDROCLORURO CORRESPONDIENTE ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA PREPARACION Y COMPUESTOS INTERMEDIOS. LOS COMPUESTOS MENCIONADOS SON UTILES PARA EL TRATAMIENTO DEL DOLOR
PE2002000624A 2001-07-17 2002-07-12 Derivados sustituidos de 4-aminociclohexanol PE20030320A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10135637A DE10135637A1 (de) 2001-07-17 2001-07-17 Substituierte 4-Aminocyclohexanolderivate
DE10135635A DE10135635A1 (de) 2001-07-17 2001-07-17 Analgetische substituierte 4-Aminocyclohexanolderivate

Publications (1)

Publication Number Publication Date
PE20030320A1 true PE20030320A1 (es) 2003-04-03

Family

ID=26009751

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2002000624A PE20030320A1 (es) 2001-07-17 2002-07-12 Derivados sustituidos de 4-aminociclohexanol

Country Status (27)

Country Link
US (1) US7678834B2 (es)
EP (1) EP1406859B1 (es)
JP (1) JP4126271B2 (es)
KR (1) KR100886579B1 (es)
CN (1) CN100584819C (es)
AR (1) AR036171A1 (es)
AT (1) ATE382601T1 (es)
AU (1) AU2002328894B2 (es)
BR (1) BR0211223A (es)
CA (1) CA2453843C (es)
CO (1) CO5550425A2 (es)
CY (1) CY1107231T1 (es)
DE (1) DE50211466D1 (es)
DK (1) DK1406859T3 (es)
ES (1) ES2298389T3 (es)
HK (1) HK1065305A1 (es)
HU (1) HU229121B1 (es)
IL (2) IL159873A0 (es)
MX (1) MXPA04000272A (es)
NO (1) NO328672B1 (es)
NZ (1) NZ531112A (es)
PE (1) PE20030320A1 (es)
PL (1) PL208792B1 (es)
PT (1) PT1406859E (es)
RU (1) RU2315750C2 (es)
SI (1) SI1406859T1 (es)
WO (1) WO2003008371A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040186310A1 (en) * 2001-06-22 2004-09-23 Kim Keun-Sik Process for preparation of cyclohexanol derivatives
JP2007204409A (ja) * 2006-02-01 2007-08-16 Sumitomo Chemical Co Ltd アルキルベンゼン化合物の製造方法
DE102006033109A1 (de) * 2006-07-18 2008-01-31 Grünenthal GmbH Substituierte Heteroaryl-Derivate
RU2488585C2 (ru) * 2007-08-31 2013-07-27 Пэдью Фарма Л.П. Замещенные пиперидиновые соединения хиноксалинового типа и их применение
US20090215725A1 (en) * 2008-02-26 2009-08-27 Grunenthal Gmbh Substituted 4-aminocyclohexane derivatives
ES2694103T3 (es) * 2008-03-27 2018-12-18 Grünenthal GmbH Derivados de 4-aminociclohexano sustituidos
AU2009228637B2 (en) * 2008-03-27 2013-12-19 Grunenthal Gmbh (Hetero-)aryl cyclohexane derivatives
JP5337809B2 (ja) * 2008-09-22 2013-11-06 日清ファルマ株式会社 抗炎症性ペプチド

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE160007C (es) 1900-01-01
FR2135883A6 (en) 1971-04-29 1972-12-22 Gryspeerdt Andre Jacquard mechanism - using upper and lower frames carrying punched plates
US4115589A (en) 1977-05-17 1978-09-19 The Upjohn Company Compounds, compositions and method of use
US4366172A (en) * 1977-09-29 1982-12-28 The Upjohn Company 4-Amino-cyclohexanols, their pharmaceutical compositions and methods of use
US4212878A (en) 1978-01-26 1980-07-15 The Upjohn Company Phenylacetamide derivative analgesics
US4346101A (en) 1980-12-08 1982-08-24 The Upjohn Company Benzamide derivative analgesics
FR2603612B1 (fr) 1986-09-05 1988-12-09 Brochier Soieries J Dispositif de variation de la densite des fils de chaine dans un metier a tisser
DE3924304A1 (de) 1989-07-22 1991-01-31 Bayer Ag Neue fluorierte cyclohexanderivate, verfahren und zwischenprodukte zu deren herstellung und die verwendung der neuen fluorierten cyclohexanderivate als fungizide und zwischenprodukte
DE4031515C1 (es) 1990-08-22 1991-10-10 Schroers Jacquard Papierind
US5304479A (en) 1991-12-06 1994-04-19 Diagnostic Reagents, Inc. Phencyclidine compounds and assays for its determination
FR2685015B1 (fr) 1991-12-12 1994-04-01 Staubli Verdol Sa Attache rapide pour la liaison d'au moins un element funiculaire par rapport a l'extremite d'un cordon.
US5239110A (en) 1992-12-30 1993-08-24 Sterling Winthrop, Inc. Phenylcyclohexanol derivatives as agents for treating CNS disorders
FR2726011B1 (fr) 1994-10-25 1996-12-20 Staubli Sa Ets Nouvel harnais demontable pour mecaniques jacquard
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE19939044A1 (de) * 1999-08-18 2001-03-15 Gruenenthal Gmbh Verwendung von Morphinanderivaten als Arzneimittel
DE19963175A1 (de) * 1999-12-27 2001-07-12 Gruenenthal Gmbh Verwendung von substituierten 4-Amino-1-phenylbutan-2-ol-Verbindungen als Arzneimittel
ATE260272T1 (de) 2000-03-17 2004-03-15 Bristol Myers Squibb Pharma Co Beta-aminsäure-derivate zur verwendung als matrix-metalloproteasen- und tna-alpha-inhibitoren
DE10135636A1 (de) * 2001-07-17 2003-02-06 Gruenenthal Gmbh Substituierte 4-Aminocyclohexanole
DE20118363U1 (de) 2001-11-13 2002-01-17 Textilma Ag, Hergiswil Chorbrett für Webmaschinen

Also Published As

Publication number Publication date
ATE382601T1 (de) 2008-01-15
IL159873A0 (en) 2004-06-20
DK1406859T3 (da) 2008-02-18
HUP0400207A2 (hu) 2004-08-30
SI1406859T1 (sl) 2008-04-30
CA2453843C (en) 2011-11-29
AU2002328894B2 (en) 2007-06-14
NZ531112A (en) 2005-09-30
JP2005504742A (ja) 2005-02-17
CO5550425A2 (es) 2005-08-31
WO2003008371A1 (de) 2003-01-30
PT1406859E (pt) 2008-01-24
AR036171A1 (es) 2004-08-18
HUP0400207A3 (en) 2008-03-28
US20040214822A1 (en) 2004-10-28
CY1107231T1 (el) 2012-11-21
CN1555355A (zh) 2004-12-15
PL208792B1 (pl) 2011-06-30
JP4126271B2 (ja) 2008-07-30
CN100584819C (zh) 2010-01-27
BR0211223A (pt) 2004-08-10
DE50211466D1 (de) 2008-02-14
EP1406859A1 (de) 2004-04-14
KR100886579B1 (ko) 2009-03-05
ES2298389T3 (es) 2008-05-16
US7678834B2 (en) 2010-03-16
NO20040162L (no) 2004-03-11
MXPA04000272A (es) 2004-05-04
RU2315750C2 (ru) 2008-01-27
CA2453843A1 (en) 2003-01-30
RU2004104628A (ru) 2005-07-10
HU229121B1 (en) 2013-08-28
IL159873A (en) 2009-02-11
HK1065305A1 (en) 2005-02-18
EP1406859B1 (de) 2008-01-02
KR20040029369A (ko) 2004-04-06
PL368040A1 (en) 2005-03-21
NO328672B1 (no) 2010-04-19

Similar Documents

Publication Publication Date Title
PE20021094A1 (es) Derivados de ciclohexano-1,4-diamina sustituidos
CO5690643A2 (es) Derivados de triaza-espiropiperidina para usarlos como inhibidores de glyt-1 en el tratamiento de desordenes neurologicos y neuropsiquiatricos
NO20072833L (no) Bi- og tricykliske substituterte fenylmetanoner som glycinetransportor I-(Glyt-1)-inhibitorer for behandling av Alzheimers sykdom
PE20070218A1 (es) COMPUESTOS DE CICLOALQUILO AMINO-HIDANTOINA Y USO DE ESTOS PARA LA MODULACION DE ß-SECRETASA
ECSP034475A (es) Derivados de 4-fenil-piridin como antagonistas del receptor de neuroquinina-1
PE20070115A1 (es) Derivados de [1,3,5]-triazina como inhibidores de aspartil proteasas
PE20001542A1 (es) Nuevos compuestos de sulfonamida y usos de los mismos
EA200701640A1 (ru) Новые соединения с терапевтическим эффектом
NO20072116L (no) Farmasoytiske forbindelser
UY29904A1 (es) Compuestos útiles en terapia
PE20071009A1 (es) Compuestos derivados de fenoxipiperidinas como antagonistas de histamina h3
JP2005527593A5 (es)
CO5700757A2 (es) Derivados de (3-oxo-3,4-dihidro-quinoxalin-2-il-amino)-benzamida y compuesto relacionado, como inhibidores de glucogeno fosforilasa para el tratamiento de la diabetes y obesidad
PE20081679A1 (es) Compuestos del inhibidor de fosfoinositida 3-cinasa y metodos de uso
AR048652A1 (es) 4-fenilamino-quinazolin-6-il-amidas
AR067845A1 (es) Compuestos para tratar trastornos relacionados con la modulacion de receptores de rianodina y composicion farmaceutica
PE20061490A1 (es) Derivados de ciclohexanosulfonilo como inhibidores del transportador de glicina glyt1
AR062299A1 (es) Derivados de bencimidazol
PE20030762A1 (es) Compuestos heterociclicos como antagonistas nk1
PE20061295A1 (es) Derivados de acetileno
PE20011371A1 (es) Derivados de 3-(3-isopropil-5-metil-4h-1,2,4-triazol-4-il)-exo-8-azabiciclo[3.2.1]octano como antagonistas de los receptores de quimiocina ccr5
ATE545413T1 (de) Antagonisten des opioidrezeptors
PE20090477A1 (es) Derivados de oxazol como inhibidores de los canales de sodio
PE20070550A1 (es) Derivados de la 1-amino-ftalazina sustituida afines al receptor mch1 y su preparacion
PE20191784A1 (es) Compuestos inhibidores de vmat2, composiciones y metodos relativos a los mismos

Legal Events

Date Code Title Description
FD Application declared void or lapsed
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载